Engineering and design software provider PTC (NASDAQ:PTC) reported in Q1 CY2025, with sales up 5.5% year on year to $636.4 ...

PTC Inc. closed 20.70% below its 52-week high of $203.09, which the company reached on December 12th.

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

This has resulted in an Earnings ESP of +1.71%. On the other hand, the stock currently carries a Zacks Rank of #3. So, this combination indicates that PTC Inc. Will most likely beat the consensus ...

PTC believes it has multiple such associations that it can present to the FDA. The biotech plans to discuss the data with Novartis, which paid $1 billion upfront for PTC518 last year, before ...

PTC Inc. (NASDAQ:PTC) defied analyst predictions ... and statutory earnings per share (EPS) coming in at US$1.35, 48% ahead of expectations. Following the result, the analysts have updated their ...

BOSTON (AP) — BOSTON (AP) — PTC Inc. (PTC) on Wednesday reported fiscal second-quarter earnings of $162.6 million. The Boston-based company said it had net income of $1.35 per share. Earnings, ...

WARREN, N.J. (AP) — WARREN, N.J. (AP) — PTC Therapeutics Inc. (PTCT ... surveyed by Zacks Investment Research was for a loss of $1.08 per share. The biopharmaceutical company posted revenue ...